Published: May 18, 2022

Neutraceuticals World

Tokiwa Phytochemical Co. Ltd announces a U.S. patent and two clinical studies supporting Bilberon, a bilberry extract, for eye and neck health. Highlighting its efficacy in reducing eye fatigue, dryness, and improving neck and shoulder stiffness, Bilberon addresses the increased screen time and its associated strain. With the backing of scientific evidence and an exclusive North American agent, Maypro, Tokiwa positions Bilberon as a solution for digital-age health concerns, including those of the growing esports market.


Read Full Article Here